25 XP   0   0   10

Clinica Baviera
Buy, Hold or Sell?

Let's analyse Clinica Baviera together

PenkeI guess you are interested in Clinica Baviera. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Clinica Baviera. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Clinica Baviera

I send you an email if I find something interesting about Clinica Baviera.

Quick analysis of Clinica Baviera (30 sec.)










What can you expect buying and holding a share of Clinica Baviera? (30 sec.)

How much money do you get?

How much money do you get?
€0.03
When do you have the money?
1 year
How often do you get paid?
74.4%

What is your share worth?

Current worth
€5.66
Expected worth in 1 year
€4.67
How sure are you?
71.8%

+ What do you gain per year?

Total Gains per Share
€-0.96
Return On Investment
-3.4%

For what price can you sell your share?

Current Price per Share
€28.40
Expected price per share
€28.00 - €29.30
How sure are you?
50%

1. Valuation of Clinica Baviera (5 min.)




Live pricePrice per Share (EOD)

€28.40

Intrinsic Value Per Share

€4.16 - €19.53

Total Value Per Share

€9.82 - €25.19

2. Growth of Clinica Baviera (5 min.)




Is Clinica Baviera growing?

Current yearPrevious yearGrowGrow %
How rich?$98.7m$83.2m$5m5.7%

How much money is Clinica Baviera making?

Current yearPrevious yearGrowGrow %
Making money$12.8m$7.8m$4.9m38.5%
Net Profit Margin16.3%14.8%--

How much money comes from the company's main activities?

3. Financial Health of Clinica Baviera (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#69 / 145

Most Revenue
#61 / 145

Most Profit
#43 / 145

What can you expect buying and holding a share of Clinica Baviera? (5 min.)

Welcome investor! Clinica Baviera's management wants to use your money to grow the business. In return you get a share of Clinica Baviera.

What can you expect buying and holding a share of Clinica Baviera?

First you should know what it really means to hold a share of Clinica Baviera. And how you can make/lose money.

Speculation

The Price per Share of Clinica Baviera is €28.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Clinica Baviera.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Clinica Baviera, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €5.66. Based on the TTM, the Book Value Change Per Share is €-0.25 per quarter. Based on the YOY, the Book Value Change Per Share is €1.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Clinica Baviera.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.592.1%0.381.3%0.441.5%0.331.2%0.230.8%
Usd Book Value Change Per Share1.756.2%-0.26-0.9%1.415.0%0.210.7%0.110.4%
Usd Dividend Per Share0.000.0%0.010.0%0.341.2%0.200.7%0.180.6%
Usd Total Gains Per Share1.756.2%-0.26-0.9%1.756.2%0.411.4%0.301.0%
Usd Price Per Share24.61-21.66-20.96-17.54-13.69-
Price to Earnings Ratio10.35-14.99-19.84-18.52-24.07-
Price-to-Total Gains Ratio14.06--5.89-41.87-42.45-82.26-
Price to Book Ratio4.06-4.72-7.88-6.58-6.58-
Price-to-Total Gains Ratio14.06--5.89-41.87-42.45-82.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share30.39368
Number of shares32
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.20
Usd Book Value Change Per Share-0.260.21
Usd Total Gains Per Share-0.260.41
Gains per Quarter (32 shares)-8.2313.16
Gains per Year (32 shares)-32.9252.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11-34-43262743
22-68-76525396
33-102-1097880149
44-135-142104107202
55-169-175130133255
66-203-208156160308
76-237-241182187361
87-271-274208213414
98-305-307234240467
109-338-340260267520

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.00.00.0100.0%61.01.00.098.4%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%14.06.00.070.0%21.011.07.053.8%30.018.014.048.4%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%16.00.04.080.0%29.00.010.074.4%41.00.021.066.1%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%16.04.00.080.0%28.05.06.071.8%42.07.013.067.7%

Fundamentals of Clinica Baviera

About Clinica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments. The company is based in Madrid, Spain.

Fundamental data was last updated by Penke on 2024-04-20 04:46:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Clinica Baviera.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Clinica Baviera earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Clinica Baviera to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 14.8% means that €0.15 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clinica Baviera:

  • The MRQ is 14.8%. The company is making a huge profit. +2
  • The TTM is 16.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.8%TTM16.3%-1.5%
TTM16.3%YOY14.8%+1.5%
TTM16.3%5Y13.5%+2.8%
5Y13.5%10Y10.9%+2.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ14.8%-6.7%+21.5%
TTM16.3%-6.7%+23.0%
YOY14.8%0.3%+14.5%
5Y13.5%-1.5%+15.0%
10Y10.9%-3.4%+14.3%
1.1.2. Return on Assets

Shows how efficient Clinica Baviera is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Clinica Baviera to the Diagnostics & Research industry mean.
  • 5.1% Return on Assets means that Clinica Baviera generated €0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clinica Baviera:

  • The MRQ is 5.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.1%TTM6.9%-1.9%
TTM6.9%YOY5.1%+1.8%
TTM6.9%5Y4.7%+2.2%
5Y4.7%10Y4.4%+0.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1%-1.3%+6.4%
TTM6.9%-1.3%+8.2%
YOY5.1%-0.9%+6.0%
5Y4.7%-0.5%+5.2%
10Y4.4%-0.9%+5.3%
1.1.3. Return on Equity

Shows how efficient Clinica Baviera is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Clinica Baviera to the Diagnostics & Research industry mean.
  • 9.9% Return on Equity means Clinica Baviera generated €0.10 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clinica Baviera:

  • The MRQ is 9.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 15.1%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.9%TTM15.1%-5.1%
TTM15.1%YOY11.1%+3.9%
TTM15.1%5Y11.8%+3.2%
5Y11.8%10Y10.5%+1.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ9.9%-0.5%+10.4%
TTM15.1%-+15.1%
YOY11.1%0.3%+10.8%
5Y11.8%-1.4%+13.2%
10Y10.5%-2.3%+12.8%

1.2. Operating Efficiency of Clinica Baviera.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Clinica Baviera is operating .

  • Measures how much profit Clinica Baviera makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Clinica Baviera to the Diagnostics & Research industry mean.
  • An Operating Margin of 21.9% means the company generated €0.22  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clinica Baviera:

  • The MRQ is 21.9%. The company is operating efficient. +1
  • The TTM is 9.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ21.9%TTM9.4%+12.5%
TTM9.4%YOY20.5%-11.1%
TTM9.4%5Y16.6%-7.2%
5Y16.6%10Y14.2%+2.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ21.9%-6.2%+28.1%
TTM9.4%0.5%+8.9%
YOY20.5%4.0%+16.5%
5Y16.6%3.7%+12.9%
10Y14.2%-1.3%+15.5%
1.2.2. Operating Ratio

Measures how efficient Clinica Baviera is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.34 means that the operating costs are €0.34 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Clinica Baviera:

  • The MRQ is 0.343. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.169. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.343TTM0.169+0.174
TTM0.169YOY0.959-0.790
TTM0.1695Y0.766-0.597
5Y0.76610Y1.032-0.266
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3431.280-0.937
TTM0.1691.304-1.135
YOY0.9591.236-0.277
5Y0.7661.242-0.476
10Y1.0321.205-0.173

1.3. Liquidity of Clinica Baviera.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Clinica Baviera is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.28 means the company has €1.28 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Clinica Baviera:

  • The MRQ is 1.276. The company is just able to pay all its short-term debts.
  • The TTM is 1.298. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.276TTM1.298-0.023
TTM1.298YOY1.427-0.128
TTM1.2985Y1.168+0.130
5Y1.16810Y0.925+0.243
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2762.111-0.835
TTM1.2982.298-1.000
YOY1.4272.599-1.172
5Y1.1683.012-1.844
10Y0.9253.081-2.156
1.3.2. Quick Ratio

Measures if Clinica Baviera is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Clinica Baviera to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.15 means the company can pay off €2.15 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clinica Baviera:

  • The MRQ is 2.147. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.651. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.147TTM1.651+0.496
TTM1.651YOY1.696-0.045
TTM1.6515Y1.373+0.278
5Y1.37310Y1.130+0.244
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1471.204+0.943
TTM1.6511.319+0.332
YOY1.6961.602+0.094
5Y1.3731.943-0.570
10Y1.1302.203-1.073

1.4. Solvency of Clinica Baviera.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Clinica Baviera assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Clinica Baviera to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.48 means that Clinica Baviera assets are financed with 48.3% credit (debt) and the remaining percentage (100% - 48.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Clinica Baviera:

  • The MRQ is 0.483. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.528. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.483TTM0.528-0.044
TTM0.528YOY0.463+0.065
TTM0.5285Y0.590-0.063
5Y0.59010Y0.572+0.018
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4830.429+0.054
TTM0.5280.407+0.121
YOY0.4630.394+0.069
5Y0.5900.450+0.140
10Y0.5720.450+0.122
1.4.2. Debt to Equity Ratio

Measures if Clinica Baviera is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Clinica Baviera to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 94.9% means that company has €0.95 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clinica Baviera:

  • The MRQ is 0.949. The company is very able to pay all its debts with equity. +2
  • The TTM is 1.135. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ0.949TTM1.135-0.185
TTM1.135YOY0.996+0.139
TTM1.1355Y1.617-0.482
5Y1.61710Y1.444+0.173
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9490.606+0.343
TTM1.1350.571+0.564
YOY0.9960.631+0.365
5Y1.6170.658+0.959
10Y1.4440.735+0.709

2. Market Valuation of Clinica Baviera

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Clinica Baviera generates.

  • Above 15 is considered overpriced but always compare Clinica Baviera to the Diagnostics & Research industry mean.
  • A PE ratio of 10.35 means the investor is paying €10.35 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clinica Baviera:

  • The EOD is 12.784. Based on the earnings, the company is underpriced. +1
  • The MRQ is 10.353. Based on the earnings, the company is underpriced. +1
  • The TTM is 14.986. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.784MRQ10.353+2.431
MRQ10.353TTM14.986-4.633
TTM14.986YOY19.839-4.853
TTM14.9865Y18.521-3.535
5Y18.52110Y24.068-5.547
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD12.784-0.235+13.019
MRQ10.353-0.395+10.748
TTM14.986-0.284+15.270
YOY19.8390.002+19.837
5Y18.5214.834+13.687
10Y24.0685.200+18.868
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Clinica Baviera:

  • The EOD is 15.683. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 12.701. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.156. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD15.683MRQ12.701+2.982
MRQ12.701TTM8.156+4.544
TTM8.156YOY57.353-49.197
TTM8.1565Y20.857-12.700
5Y20.85710Y29.127-8.270
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD15.683-0.277+15.960
MRQ12.701-0.441+13.142
TTM8.156-1.389+9.545
YOY57.353-2.030+59.383
5Y20.857-1.446+22.303
10Y29.127-1.971+31.098
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Clinica Baviera is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 4.06 means the investor is paying €4.06 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Clinica Baviera:

  • The EOD is 5.017. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.063. Based on the equity, the company is fair priced.
  • The TTM is 4.722. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.017MRQ4.063+0.954
MRQ4.063TTM4.722-0.658
TTM4.722YOY7.880-3.158
TTM4.7225Y6.578-1.856
5Y6.57810Y6.581-0.003
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD5.0171.897+3.120
MRQ4.0632.222+1.841
TTM4.7222.168+2.554
YOY7.8803.041+4.839
5Y6.5783.477+3.101
10Y6.5814.125+2.456
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Clinica Baviera compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.634-0.247+115%1.321+24%0.195+739%0.105+1452%
Book Value Per Share--5.6604.346+30%3.521+61%2.948+92%2.178+160%
Current Ratio--1.2761.298-2%1.427-11%1.168+9%0.925+38%
Debt To Asset Ratio--0.4830.528-8%0.463+4%0.590-18%0.572-16%
Debt To Equity Ratio--0.9491.135-16%0.996-5%1.617-41%1.444-34%
Dividend Per Share--0.0020.007-69%0.317-99%0.190-99%0.170-99%
Eps--0.5550.358+55%0.410+36%0.309+80%0.219+154%
Free Cash Flow Per Share--0.4530.651-30%0.456-1%0.428+6%0.334+36%
Free Cash Flow To Equity Per Share--0.2950.499-41%0.134+120%0.188+56%0.181+63%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--19.526--------
Intrinsic Value_10Y_min--4.156--------
Intrinsic Value_1Y_max--2.056--------
Intrinsic Value_1Y_min--1.186--------
Intrinsic Value_3Y_max--6.101--------
Intrinsic Value_3Y_min--2.919--------
Intrinsic Value_5Y_max--10.055--------
Intrinsic Value_5Y_min--3.930--------
Market Cap462917160.000+19%374954579.000387762862.900-3%560553468.400-33%352741505.273+6%252439315.314+49%
Net Profit Margin--0.1480.163-9%0.1480%0.135+9%0.109+35%
Operating Margin--0.2190.094+133%0.205+7%0.166+32%0.142+54%
Operating Ratio--0.3430.169+102%0.959-64%0.766-55%1.032-67%
Pb Ratio5.017+19%4.0634.722-14%7.880-48%6.578-38%6.581-38%
Pe Ratio12.784+19%10.35314.986-31%19.839-48%18.521-44%24.068-57%
Price Per Share28.400+19%23.00020.238+14%19.588+17%16.388+40%12.792+80%
Price To Free Cash Flow Ratio15.683+19%12.7018.156+56%57.353-78%20.857-39%29.127-56%
Price To Total Gains Ratio17.360+19%14.059-5.889+142%41.867-66%42.449-67%82.262-83%
Quick Ratio--2.1471.651+30%1.696+27%1.373+56%1.130+90%
Return On Assets--0.0510.069-27%0.051-1%0.047+7%0.044+16%
Return On Equity--0.0990.151-34%0.111-11%0.118-16%0.105-5%
Total Gains Per Share--1.636-0.240+115%1.6380%0.384+326%0.276+493%
Usd Book Value--98753209.06488348614.166+12%83269306.643+19%60086702.950+64%42439498.912+133%
Usd Book Value Change Per Share--1.749-0.264+115%1.414+24%0.208+739%0.113+1452%
Usd Book Value Per Share--6.0584.651+30%3.768+61%3.155+92%2.331+160%
Usd Dividend Per Share--0.0020.007-69%0.340-99%0.203-99%0.182-99%
Usd Eps--0.5940.383+55%0.438+36%0.330+80%0.234+154%
Usd Free Cash Flow--7898730.96210118637.191-22%10527128.250-25%8202848.145-4%5344202.666+48%
Usd Free Cash Flow Per Share--0.4850.697-30%0.488-1%0.458+6%0.357+36%
Usd Free Cash Flow To Equity Per Share--0.3150.535-41%0.144+120%0.202+56%0.194+63%
Usd Market Cap495413944.632+19%401276390.446414983815.876-3%599904321.882-33%377503958.943+6%270160555.249+49%
Usd Price Per Share30.394+19%24.61521.658+14%20.963+17%17.538+40%13.690+80%
Usd Profit--9689513.74612847731.736-25%7897682.166+23%7045358.138+38%4672594.320+107%
Usd Revenue--65638524.16076069535.340-14%53095096.838+24%48290498.845+36%37145482.864+77%
Usd Total Gains Per Share--1.751-0.257+115%1.7530%0.411+326%0.295+493%
 EOD+4 -4MRQTTM+17 -18YOY+19 -165Y+29 -610Y+30 -5

3.2. Fundamental Score

Let's check the fundamental score of Clinica Baviera based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.784
Price to Book Ratio (EOD)Between0-15.017
Net Profit Margin (MRQ)Greater than00.148
Operating Margin (MRQ)Greater than00.219
Quick Ratio (MRQ)Greater than12.147
Current Ratio (MRQ)Greater than11.276
Debt to Asset Ratio (MRQ)Less than10.483
Debt to Equity Ratio (MRQ)Less than10.949
Return on Equity (MRQ)Greater than0.150.099
Return on Assets (MRQ)Greater than0.050.051
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Clinica Baviera based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.552
Ma 20Greater thanMa 5028.350
Ma 50Greater thanMa 10027.364
Ma 100Greater thanMa 20025.430
OpenGreater thanClose28.300
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets178,642
Total Liabilities86,367
Total Stockholder Equity90,996
 As reported
Total Liabilities 86,367
Total Stockholder Equity+ 90,996
Total Assets = 178,642

Assets

Total Assets178,642
Total Current Assets57,741
Long-term Assets120,901
Total Current Assets
Cash And Cash Equivalents 8,306
Short-term Investments 42,934
Net Receivables 3,013
Inventory 2,473
Other Current Assets 1,014
Total Current Assets  (as reported)57,741
Total Current Assets  (calculated)57,741
+/-0
Long-term Assets
Property Plant Equipment 99,060
Goodwill 14,616
Intangible Assets 2,747
Long-term Assets  (as reported)120,901
Long-term Assets  (calculated)116,422
+/- 4,479

Liabilities & Shareholders' Equity

Total Current Liabilities45,266
Long-term Liabilities41,101
Total Stockholder Equity90,996
Total Current Liabilities
Short-term Debt 10,755
Short Long Term Debt 2,115
Accounts payable 15,524
Other Current Liabilities 18,987
Total Current Liabilities  (as reported)45,266
Total Current Liabilities  (calculated)47,381
+/- 2,115
Long-term Liabilities
Capital Lease Obligations 44,752
Long-term Liabilities  (as reported)41,101
Long-term Liabilities  (calculated)44,752
+/- 3,651
Total Stockholder Equity
Common Stock1,631
Retained Earnings 35,971
Other Stockholders Equity 53,395
Total Stockholder Equity (as reported)90,996
Total Stockholder Equity (calculated)90,996
+/-0
Other
Capital Stock1,631
Cash and Short Term Investments 51,241
Common Stock Shares Outstanding 16,302
Liabilities and Stockholders Equity 178,642
Net Debt 39,108
Net Invested Capital 93,659
Net Working Capital 12,476
Property Plant and Equipment Gross 234,149
Short Long Term Debt Total 47,415



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-06-302010-03-312009-12-312009-06-302009-03-312008-12-312008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312005-09-30
> Total Assets 
30,112
43,392
0
42,865
0
45,248
0
71,251
64,119
0
63,335
58,753
0
59,908
56,842
0
58,831
0
57,856
0
56,763
0
51,668
0
49,603
0
48,278
0
46,664
0
49,038
0
47,550
0
46,380
0
49,707
0
46,767
48,692
49,321
0
53,992
0
54,174
54,470
55,830
94,834
95,416
97,310
101,564
109,783
109,228
113,627
120,922
129,510
127,671
130,918
133,809
142,211
142,356
143,352
149,080
174,676
170,190
175,160
178,642
178,642175,160170,190174,676149,080143,352142,356142,211133,809130,918127,671129,510120,922113,627109,228109,783101,56497,31095,41694,83455,83054,47054,174053,992049,32148,69246,767049,707046,380047,550049,038046,664048,278049,603051,668056,763057,856058,831056,84259,908058,75363,335064,11971,251045,248042,865043,39230,112
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
17,254
0
19,650
16,398
0
18,485
0
16,048
0
15,162
0
12,597
0
16,946
0
16,735
0
15,303
0
16,679
0
14,905
0
15,007
0
18,032
0
13,998
15,474
15,322
0
15,586
0
14,400
13,233
12,695
13,987
11,508
10,893
11,174
21,072
20,898
26,833
31,378
37,703
36,472
39,399
37,923
49,018
47,174
47,452
44,609
56,369
47,670
51,246
57,741
57,74151,24647,67056,36944,60947,45247,17449,01837,92339,39936,47237,70331,37826,83320,89821,07211,17410,89311,50813,98712,69513,23314,400015,586015,32215,47413,998018,032015,007014,905016,679015,303016,735016,946012,597015,162016,048018,485016,39819,650017,25400000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
13,964
0
16,556
13,571
0
15,851
0
13,852
0
12,674
0
9,404
0
15,114
0
12,726
0
10,287
0
2,761
0
3,016
0
4,587
0
5,815
0
4,026
13,486
5,077
0
5,677
0
4,487
10,648
3,911
10,793
5,202
7,882
3,921
17,124
7,958
22,463
10,822
32,565
14,852
35,304
9,801
44,070
14,622
42,582
19,173
0
10,984
46,409
8,306
8,30646,40910,984019,17342,58214,62244,0709,80135,30414,85232,56510,82222,4637,95817,1243,9217,8825,20210,7933,91110,6484,48705,67705,07713,4864,02605,81504,58703,01602,761010,287012,726015,11409,404012,674013,852015,851013,57116,556013,96400000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,258
0
9,358
0
8,525
0
9,944
0
7,799
0
8,199
0
6,538
0
6,134
0
5,893
0
2,994
0
2,567
0
8,567
0
16,114
0
17,064
0
22,471
0
27,471
0
19,817
0
30,459
0
42,934
42,934030,459019,817027,471022,471017,064016,11408,56702,56702,99405,89306,13406,53808,19907,79909,94408,52509,358010,258000000000000000000000000000000
       Net Receivables 
1,260
2,205
0
3,614
0
2,272
0
4,063
2,814
0
4,000
2,721
0
2,256
1,923
0
1,694
0
1,347
0
1,507
0
1,502
0
898
0
1,282
0
1,139
0
1,288
0
861
0
949
0
1,486
0
1,377
1,988
1,213
0
1,908
0
1,770
2,585
1,336
3,194
1,677
3,011
2,818
3,948
2,117
4,370
2,343
2,344
2,344
4,095
3,447
4,948
2,466
4,870
2,873
0
3,356
4,837
3,013
3,0134,8373,35602,8734,8702,4664,9483,4474,0952,3442,3442,3434,3702,1173,9482,8183,0111,6773,1941,3362,5851,77001,90801,2131,9881,37701,4860949086101,28801,13901,282089801,50201,50701,34701,69401,9232,25602,7214,00002,8144,06302,27203,61402,2051,260
       Inventory 
218
492
0
553
0
679
0
753
594
0
527
554
0
698
833
0
764
0
733
0
736
0
1,507
0
874
0
2,400
0
3,811
0
2,223
0
1,546
0
847
0
705
0
722
0
668
0
943
0
1,255
0
989
0
969
0
1,198
0
1,428
0
1,642
1,835
1,835
0
1,933
0
2,091
0
2,162
0
2,428
0
2,473
2,47302,42802,16202,09101,93301,8351,8351,64201,42801,1980969098901,2550943066807220705084701,54602,22303,81102,400087401,507073607330764083369805545270594753067905530492218
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
41,499
0
40,258
40,444
0
40,346
0
41,808
0
41,601
0
39,071
0
32,657
0
31,543
0
31,361
0
32,359
0
32,645
0
31,372
0
31,675
0
32,769
33,218
33,999
0
38,406
0
39,774
41,238
43,135
80,847
83,908
86,417
90,390
88,711
88,330
86,794
89,544
91,806
91,199
91,519
95,886
93,192
95,182
95,900
1,011
118,307
122,520
123,914
120,901
120,901123,914122,520118,3071,01195,90095,18293,19295,88691,51991,19991,80689,54486,79488,33088,71190,39086,41783,90880,84743,13541,23839,774038,406033,99933,21832,769031,675031,372032,645032,359031,361031,543032,657039,071041,601041,808040,346040,44440,258041,49900000000000
       Property Plant Equipment 
8,488
12,545
0
17,559
0
20,983
0
25,843
26,676
0
24,371
21,794
0
20,681
20,386
0
19,831
0
21,401
0
21,018
0
21,143
0
16,569
0
16,646
0
16,502
0
17,268
0
17,416
0
16,477
0
16,685
0
18,175
18,527
18,791
0
23,002
0
24,095
25,583
27,479
28,332
66,430
68,971
72,939
71,276
70,882
69,318
71,403
73,362
72,347
72,391
77,253
74,396
76,173
76,835
86,079
0
90,441
92,735
99,060
99,06092,73590,441086,07976,83576,17374,39677,25372,39172,34773,36271,40369,31870,88271,27672,93968,97166,43028,33227,47925,58324,095023,002018,79118,52718,175016,685016,477017,416017,268016,502016,646016,569021,143021,018021,401019,831020,38620,681021,79424,371026,67625,843020,983017,559012,5458,488
       Goodwill 
81
9,518
0
9,485
0
9,299
0
23,803
19,544
0
18,645
17,990
0
17,946
17,892
0
17,927
0
17,497
0
17,597
0
14,393
0
12,869
0
12,785
0
12,785
0
12,785
0
12,785
0
12,785
0
12,890
0
12,785
0
13,299
0
13,458
0
13,458
0
13,458
0
14,652
0
14,616
0
14,616
0
14,616
0
14,616
0
14,616
0
14,616
0
14,616
0
14,616
0
14,616
14,616014,616014,616014,616014,616014,616014,616014,616014,616014,652013,458013,458013,458013,299012,785012,890012,785012,785012,785012,785012,785012,869014,393017,597017,497017,927017,89217,946017,99018,645019,54423,80309,29909,48509,51881
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,509
0
0
0
0
0
1,733
0
2,437
1,772
2,511
44
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000442,5111,7722,43701,733000001,509000000000000000000000000000000000000000
       Intangible Assets 
175
9,633
0
9,620
0
9,574
0
23,885
19,795
0
18,913
249
0
172
104
0
17,989
0
63
0
219
0
205
0
211
0
162
0
123
0
123
0
197
0
300
0
305
0
341
13,182
377
0
508
0
486
13,922
468
50,078
350
14,935
312
0
272
0
564
0
1,266
0
998
0
1,238
0
461
0
1,346
0
2,747
2,74701,346046101,238099801,26605640272031214,93535050,07846813,9224860508037713,182341030503000197012301230162021102050219063017,9890104172024918,913019,79523,88509,57409,62009,633175
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
954
0
1,031
977
0
2,526
0
1,534
0
1,454
0
1,435
0
1,210
0
1,521
0
1,522
0
10,603
0
9,358
0
8,525
0
9,944
0
7,799
1,509
8,199
0
6,538
0
6,134
1,733
5,893
2,437
2,994
2,511
2,808
2,538
8,567
2,567
16,314
2,982
17,064
2,964
22,671
3,054
27,471
3,177
-84,667
0
30,459
2,113
42,934
42,9342,11330,4590-84,6673,17727,4713,05422,6712,96417,0642,98216,3142,5678,5672,5382,8082,5112,9942,4375,8931,7336,13406,53808,1991,5097,79909,94408,52509,358010,60301,52201,52101,21001,43501,45401,53402,52609771,031095400000000000
> Total Liabilities 
15,775
23,901
0
28,089
0
25,370
0
52,650
45,095
0
43,180
37,887
0
36,887
34,438
0
34,413
0
34,029
0
33,778
0
30,811
0
27,007
0
22,933
0
26,964
0
28,835
0
27,388
0
25,067
0
25,748
0
28,192
27,505
29,249
0
29,114
0
30,229
29,495
27,067
63,643
70,248
70,769
70,760
76,878
75,343
75,100
76,017
76,848
75,708
73,399
78,415
75,721
76,455
72,897
40,697
94,695
93,948
93,445
86,367
86,36793,44593,94894,69540,69772,89776,45575,72178,41573,39975,70876,84876,01775,10075,34376,87870,76070,76970,24863,64327,06729,49530,229029,114029,24927,50528,192025,748025,067027,388028,835026,964022,933027,007030,811033,778034,029034,413034,43836,887037,88743,180045,09552,650025,370028,089023,90115,775
   > Total Current Liabilities 
8,848
11,145
0
15,635
0
14,295
0
22,357
18,974
0
17,398
16,013
0
15,821
17,116
0
15,618
0
16,888
0
13,896
0
16,691
0
11,531
0
14,517
0
13,062
0
15,479
0
11,491
0
13,904
0
12,659
0
15,950
11,129
13,466
0
18,593
0
18,977
13,427
18,431
15,353
29,694
15,631
27,690
15,454
27,765
18,607
32,348
21,808
33,990
23,797
35,222
28,077
37,467
29,392
41,039
42,452
41,941
35,246
45,266
45,26635,24641,94142,45241,03929,39237,46728,07735,22223,79733,99021,80832,34818,60727,76515,45427,69015,63129,69415,35318,43113,42718,977018,593013,46611,12915,950012,659013,904011,491015,479013,062014,517011,531016,691013,896016,888015,618017,11615,821016,01317,398018,97422,357014,295015,635011,1458,848
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
4,533
0
0
4,813
0
0
0
5,837
0
3,193
0
6,255
0
3,159
0
5,428
0
3,016
0
4,475
0
2,367
0
4,366
0
2,192
0
5,637
16,376
3,593
18,151
5,516
14,748
6,093
0
5,749
0
8,840
0
11,851
0
6,105
0
13,131
0
5,083
0
11,664
0
3,792
0
2,006
0
2,011
0
10,755
10,75502,01102,00603,792011,66405,083013,13106,105011,85108,84005,74906,09314,7485,51618,1513,59316,3765,63702,19204,36602,36704,47503,01605,42803,15906,25503,19305,8370004,813004,53300000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,533
16,376
18,151
18,151
5,516
14,748
6,093
0
5,649
0
8,840
0
4,417
0
6,105
0
5,876
0
5,083
0
4,203
0
3,792
0
2,006
0
2,011
0
2,115
2,11502,01102,00603,79204,20305,08305,87606,10504,41708,84005,64906,09314,7485,51618,15118,15116,37616,53300000000000000000000000000000000000000
       Accounts payable 
1,689
2,421
0
4,634
0
6,276
0
12,402
8,106
0
7,118
6,780
0
2,566
6,581
0
6,126
0
7,086
0
2,831
0
6,862
0
2,693
0
6,862
0
5,719
0
6,836
0
4,281
0
6,747
0
3,671
0
5,982
6,817
2,957
0
8,180
0
3,346
7,741
7,025
8,854
3,553
9,019
8,151
8,924
2,714
11,419
9,937
12,042
4,490
10,265
12,336
12,886
5,972
12,505
14,980
0
6,710
14,399
15,524
15,52414,3996,710014,98012,5055,97212,88612,33610,2654,49012,0429,93711,4192,7148,9248,1519,0193,5538,8547,0257,7413,34608,18002,9576,8175,98203,67106,74704,28106,83605,71906,86202,69306,86202,83107,08606,12606,5812,56606,7807,11808,10612,40206,27604,63402,4211,689
       Other Current Liabilities 
4,358
5,780
0
8,057
0
4,819
0
6,045
6,470
0
6,321
4,700
0
13,255
5,722
0
9,492
0
1,835
0
2,058
0
3,574
0
1,384
0
2,226
0
1,365
0
4,169
0
1,391
0
2,790
0
1,539
0
4,331
4,312
1,539
0
4,897
0
1,474
5,686
5,657
6,499
2,064
6,612
7,688
6,530
1,803
7,188
9,280
9,766
2,426
13,532
11,222
15,191
27,703
16,887
24,052
42,452
4,523
20,847
18,987
18,98720,8474,52342,45224,05216,88727,70315,19111,22213,5322,4269,7669,2807,1881,8036,5307,6886,6122,0646,4995,6575,6861,47404,89701,5394,3124,33101,53902,79001,39104,16901,36502,22601,38403,57402,05801,83509,49205,72213,25504,7006,32106,4706,04504,81908,05705,7804,358
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
21,874
0
21,066
17,322
0
18,795
0
17,141
0
19,882
0
14,120
0
15,476
0
8,416
0
13,902
0
13,356
0
15,897
0
11,164
0
13,089
0
12,242
16,376
15,783
0
10,521
0
11,252
16,068
8,635
48,290
40,554
55,138
43,070
61,424
47,578
56,493
43,669
55,040
41,718
49,602
43,193
47,644
38,988
43,505
40,697
52,243
52,007
58,199
41,101
41,10158,19952,00752,24340,69743,50538,98847,64443,19349,60241,71855,04043,66956,49347,57861,42443,07055,13840,55448,2908,63516,06811,252010,521015,78316,37612,242013,089011,164015,897013,356013,90208,416015,476014,120019,882017,141018,795017,32221,066021,87400000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,526
0
2,516
0
47,674
0
0
0047,67402,516047,526000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
-4,533
0
0
-4,813
0
0
0
-5,837
0
-3,193
0
-6,255
0
-3,159
0
-5,428
0
-3,016
0
-4,475
0
-2,367
0
-4,366
0
-2,192
0
-5,637
-16,376
-3,593
-18,151
-5,516
-14,748
-6,093
0
-5,749
35,851
-8,840
38,285
29,368
40,242
-6,105
38,598
25,211
40,118
-5,083
37,573
29,165
38,119
-3,792
38,383
33,406
0
-2,011
43,537
33,998
33,99843,537-2,011033,40638,383-3,79238,11929,16537,573-5,08340,11825,21138,598-6,10540,24229,36838,285-8,84035,851-5,7490-6,093-14,748-5,516-18,151-3,593-16,376-5,6370-2,1920-4,3660-2,3670-4,4750-3,0160-5,4280-3,1590-6,2550-3,1930-5,837000-4,81300-4,53300000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
175
0
86
0
83
0
1
0
96
0
140
645
101
0
100
0
0
0
101
0
0101000100010164514009601083086017500000000000000000000000000000000000000000000000
> Total Stockholder Equity
14,225
19,336
19,490
14,500
14,776
19,707
19,878
18,447
19,088
19,024
20,249
20,866
20,866
22,990
22,412
22,404
24,418
24,418
23,719
23,827
22,987
0
21,354
20,856
22,489
0
24,949
25,346
19,328
19,700
19,903
20,203
19,836
20,162
21,070
21,312
23,851
0
18,504
21,076
19,840
19,840
24,584
24,879
23,648
24,705
28,486
30,924
24,887
26,341
30,592
32,674
33,647
38,193
44,492
52,110
51,470
56,934
54,604
65,443
65,095
69,540
67,344
79,981
75,306
80,719
90,996
90,99680,71975,30679,98167,34469,54065,09565,44354,60456,93451,47052,11044,49238,19333,64732,67430,59226,34124,88730,92428,48624,70523,64824,87924,58419,84019,84021,07618,504023,85121,31221,07020,16219,83620,20319,90319,70019,32825,34624,949022,48920,85621,354022,98723,82723,71924,41824,41822,40422,41222,99020,86620,86620,24919,02419,08818,44719,87819,70714,77614,50019,49019,33614,225
   Common Stock
1,626
1,631
0
1,631
0
1,631
0
1,631
1,631
0
1,631
1,631
0
1,631
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
0
1,631
21,076
1,631
0
1,631
0
1,631
24,705
1,631
30,924
1,631
26,341
1,631
32,674
1,631
38,193
1,631
1,631
1,631
56,934
1,631
65,443
1,631
69,540
1,631
0
1,631
80,719
1,631
1,63180,7191,63101,63169,5401,63165,4431,63156,9341,6311,6311,63138,1931,63132,6741,63126,3411,63130,9241,63124,7051,63101,63101,63121,0761,63101,63101,63101,63101,63101,63101,63101,63101,63101,63101,63101,63101,6311,63101,6311,63101,6311,63101,63101,63101,6311,626
   Retained Earnings 
7,725
13,000
0
7,308
0
13,163
0
11,922
12,463
0
13,540
1,861
0
3,975
5,220
0
18,153
0
3,482
0
-22
0
-88
0
3,580
0
4,887
0
2,265
0
4,055
0
2,000
0
4,880
0
5,194
0
7,914
0
4,923
0
9,770
0
6,936
0
11,826
0
7,160
0
12,795
0
3,082
0
13,942
16,079
16,079
0
27,390
0
19,150
0
29,519
0
20,988
0
35,971
35,971020,988029,519019,150027,390016,07916,07913,94203,082012,79507,160011,82606,93609,77004,92307,91405,19404,88002,00004,05502,26504,88703,5800-880-2203,482018,15305,2203,97501,86113,540012,46311,922013,16307,308013,0007,725
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,894
0
0
0
0
00004,89400000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000-710-90-50-50-590-400-400-400-90-90-950-950-8850-5930-8110-778-77800000000000-2000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
17,374
0
17,384
15,561
0
24,418
0
18,606
0
21,378
0
19,811
0
17,278
0
18,431
0
15,432
0
14,218
0
16,205
0
14,560
0
17,026
0
8,959
21,076
13,286
0
13,184
0
15,081
24,705
15,029
30,924
16,096
26,341
16,166
32,674
28,934
38,193
28,920
52,110
33,760
56,934
25,583
65,443
44,314
69,540
-24,718
0
52,687
0
53,395
53,395052,6870-24,71869,54044,31465,44325,58356,93433,76052,11028,92038,19328,93432,67416,16626,34116,09630,92415,02924,70515,081013,184013,28621,0768,959017,026014,560016,205014,218015,432018,431017,278019,811021,378018,606024,418015,56117,384017,37400000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue224,924
Cost of Revenue-129,938
Gross Profit94,98694,986
 
Operating Income (+$)
Gross Profit94,986
Operating Expense-44,945
Operating Income50,04150,041
 
Operating Expense (+$)
Research Development0
Selling General Administrative15,852
Selling And Marketing Expenses10,311
Operating Expense44,94526,162
 
Net Interest Income (+$)
Interest Income151
Interest Expense-572
Other Finance Cost-112
Net Interest Income-309
 
Pretax Income (+$)
Operating Income50,041
Net Interest Income-309
Other Non-Operating Income Expenses0
Income Before Tax (EBT)49,66850,414
EBIT - interestExpense = 49,469
48,890
36,543
Interest Expense572
Earnings Before Interest and Taxes (EBIT)50,04150,239
Earnings Before Interest and Taxes (EBITDA)67,021
 
After tax Income (+$)
Income Before Tax49,668
Tax Provision-11,531
Net Income From Continuing Ops32,89638,137
Net Income35,971
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses174,883
Total Other Income/Expenses Net-373309
 

Technical Analysis of Clinica Baviera
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Clinica Baviera. The general trend of Clinica Baviera is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Clinica Baviera's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Clinica Baviera.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 29.00 < 29.00 < 29.30.

The bearish price targets are: 28.00 > 28.00 > 28.00.

Tweet this
Clinica Baviera Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Clinica Baviera. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Clinica Baviera Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Clinica Baviera. The current macd is 0.19277645.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Clinica Baviera price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Clinica Baviera. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Clinica Baviera price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Clinica Baviera Daily Moving Average Convergence/Divergence (MACD) ChartClinica Baviera Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Clinica Baviera. The current adx is 11.32.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Clinica Baviera shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Clinica Baviera Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Clinica Baviera. The current sar is 28.73.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Clinica Baviera Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Clinica Baviera. The current rsi is 54.55. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Clinica Baviera Daily Relative Strength Index (RSI) ChartClinica Baviera Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Clinica Baviera. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Clinica Baviera price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Clinica Baviera Daily Stochastic Oscillator ChartClinica Baviera Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Clinica Baviera. The current cci is -37.97468354.

Clinica Baviera Daily Commodity Channel Index (CCI) ChartClinica Baviera Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Clinica Baviera. The current cmo is 6.47471837.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Clinica Baviera Daily Chande Momentum Oscillator (CMO) ChartClinica Baviera Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Clinica Baviera. The current willr is -54.54545455.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Clinica Baviera is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Clinica Baviera Daily Williams %R ChartClinica Baviera Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Clinica Baviera.

Clinica Baviera Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Clinica Baviera. The current atr is 0.57153494.

Clinica Baviera Daily Average True Range (ATR) ChartClinica Baviera Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Clinica Baviera. The current obv is -28,688.

Clinica Baviera Daily On-Balance Volume (OBV) ChartClinica Baviera Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Clinica Baviera. The current mfi is 41.65.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Clinica Baviera Daily Money Flow Index (MFI) ChartClinica Baviera Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Clinica Baviera.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Clinica Baviera Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Clinica Baviera based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.552
Ma 20Greater thanMa 5028.350
Ma 50Greater thanMa 10027.364
Ma 100Greater thanMa 20025.430
OpenGreater thanClose28.300
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Clinica Baviera with someone you think should read this too:
  • Are you bullish or bearish on Clinica Baviera? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Clinica Baviera? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Clinica Baviera

I send you an email if I find something interesting about Clinica Baviera.


Comments

How you think about this?

Leave a comment

Stay informed about Clinica Baviera.

Receive notifications about Clinica Baviera in your mailbox!